NCT06957691
- Conditions
- Adenocarcinoma, Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma, Androgen Deprivation Therapy, +40 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
Clinical trial condition
Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
Explore clinical trials studying Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma trial results
Completed
Effectiveness and Safety of Firmagon®
NCT00930319
- Conditions
- Androgen Ablative Therapy of Advanced Hormone-dependent Prostate Carcinoma
- Locations
-
- Investigational Site, Heinrich-Rieger-Str. 15 Aalen, Germany
- Investigational Site, Weidenfelder Straße 1 Aalen, Germany
- Investigational Site Abensberg, Germany
- Investigational Site Ahaus, Germany